InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-06 · accession 0001127602-22-003846 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-02-08 2022-02-06 GILD Pletcher Brett A EVP, Corp Affairs, Gen Counsel F - Tax $63.90 -1,036 34.3K -3% -$66.2K
D 2022-02-08 2022-02-06 GILD Pletcher Brett A EVP, Corp Affairs, Gen Counsel M - OptEx $0.00 +2,727 35.3K +8% $0
D 2022-02-08 2022-02-06 GILD Pletcher Brett A EVP, Corp Affairs, Gen Counsel M - OptEx — -2,727 23.0K -11% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-06 F D 1,036 $63.90 34,267 D — —
2 Common Common Stock 2022-02-06 M A 2,727 $0.00 35,303 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
3 Derivative Restricted Stock Unit 2022-02-06 M D 2,727 — 23,024 D — · — to — 2,727 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.